Results 151 to 160 of about 25,505 (239)

Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease

open access: yes, 2019
Huntington's disease is a neurodegenerative disorder caused by a CAG repeat expansion in the first exon of huntingtin gene (HTT) encoding for a toxic polyglutamine protein.
Leumann, Christian   +4 more
core   +1 more source

Huntingtin and mitosis

open access: yes
Huntingtine et mitose La maladie de Huntington (MH) est une maladie neurodégénérative héréditaire autosomique dominante. Elle résulte d’une expansion anormale de glutamines (polyQ) dans la partie N-terminale de la protéine huntingtine (HTT ; codé par HTT).
openaire   +2 more sources

Transient Interdomain Interactions Modulate the Monomeric Structural Ensemble and Self‐Assembly of Huntingtin Exon 1

open access: yesAdvanced Science
Polyglutamine (polyQ) tract length expansion (≥ 36 residues) within the N‐terminal exon‐1 of Huntingtin (Httex1) leads to Huntington's disease, a neurodegenerative condition marked by the presence of intranuclear Htt inclusions.
Priyesh Mohanty   +2 more
doaj   +1 more source

Huntingtin [PDF]

open access: yes, 2019
openaire   +1 more source

Inhibition of calcineurin by FK506 protects against polyglutamine-huntingtin toxicity through an increase of huntingtin phosphorylation at S421

open access: yes
Huntington's disease (HD) is caused by an abnormal expanded polyglutamine (polyQ) repeat in the huntingtin protein. Insulin-like growth factor-1 acting through the prosurvival kinase Akt mediates the phosphorylation of huntingtin at S421 and inhibits the
Deglon, N.   +6 more
core   +1 more source

Striatal Neuron Excitability Is Regulated by Huntingtin in the Adult Brain. [PDF]

open access: yeseNeuro
Barron JC   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy